KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $8.3 billion.

  • Medtronic's Cash & Current Investments rose 423.08% to $8.3 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $8.3 billion, marking a year-over-year increase of 423.08%. This contributed to the annual value of $9.0 billion for FY2025, which is 1199.25% up from last year.
  • Medtronic's Cash & Current Investments amounted to $8.3 billion in Q4 2025, which was up 423.08% from $8.1 billion recorded in Q3 2025.
  • Medtronic's Cash & Current Investments' 5-year high stood at $14.6 billion during Q1 2021, with a 5-year trough of $7.7 billion in Q4 2023.
  • In the last 5 years, Medtronic's Cash & Current Investments had a median value of $8.6 billion in 2022 and averaged $9.5 billion.
  • As far as peak fluctuations go, Medtronic's Cash & Current Investments soared by 2589.44% in 2021, and later tumbled by 3233.6% in 2023.
  • Over the past 5 years, Medtronic's Cash & Current Investments (Quarter) stood at $10.7 billion in 2021, then increased by 7.13% to $11.4 billion in 2022, then tumbled by 32.34% to $7.7 billion in 2023, then rose by 3.3% to $8.0 billion in 2024, then increased by 4.23% to $8.3 billion in 2025.
  • Its Cash & Current Investments stands at $8.3 billion for Q4 2025, versus $8.1 billion for Q3 2025 and $9.0 billion for Q2 2025.